Skip to main content
. 2021 Sep 16;11:720052. doi: 10.3389/fonc.2021.720052

Table 2.

Univariate analysis for locoregional recurrence.

Variable Test Hazard ratio (95% CI) P-value
Sex Female vs. male 0.928 (0.514, 1.675) 0.8039
Age +1 year 1.010 (0.987, 1.033) 0.3938
Smoking Global test 0.3281
Current smoker vs. stopped >6 m 1.462 (0.843, 2.536) 0.1764
Current smoker vs. never 1.370 (0.655, 2.863) 0.4029
Stopped >6 m vs. never 0.937 (0.401, 2.189) 0.8805
Ethyl Global test 0.0064
Stopped vs. yes 2.215 (1.290, 3.801) 0.0039
Stopped vs. none 1.997 (1.195, 3.340) 0.0083
Yes vs. none 0.902 (0.537, 1.513) 0.6956
Grade +1 level 0.574 (0.369, 0.892) 0.0136
Highest TNM stagea +1 level 1.935 (1.343, 2.788) 0.0004
Oral Yes vs. no 1.888 (0.764, 4.664) 0.1683
Oropharynx Yes vs. no 0.734 (0.475, 1.133) 0.1621
Glottis Yes vs. no 0.939 (0.485, 1.817) 0.8513
Hypopharynx Yes vs. no 1.435 (0.889, 2.316) 0.1396
Supraglottis Yes vs. no 1.428 (0.885, 2.305) 0.1442

Continuous variables: HR > (<) 1 means higher (lower) risk for increasing level. Categorical variables: pairwise tests only presented if significant global P-value. Binary variables/pairwise tests: R > (<) 1 means higher (lower) risk for first category.

CI, confidence interval; m, months; TNM, tumor, node, metastasis stage.

a

In case patients had multiple tumors, the tumor with the highest TNM stage was used.